ArticlePacific Symposium on Biocomputing. Pacific Symposium on Biocomputing2020
Implementing a Cloud Based Method for Protected Clinical Trial Data Sharing.
Article in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Data Sharing Goals for Nonprofit Funders of Clinical Trials.Journal of participatory medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Clinical trials generate a large amount of data that have been underutilized due to obstacles that prevent data sharing including risking patient privacy, data misrepresentation, and invalid secondary analyses. In order to address these obstacles, we developed a novel data sharing method which ensures patient privacy while also protecting the interests of clinical trial investigators. Our flexible and robust approach involves two components: (1) an advanced cloud-based querying language that allows users to test hypotheses without direct access to the real clinical trial data and (2) corresponding synthetic data for the query of interest that allows for exploratory research and model development. Both components can be modified by the clinical trial investigator depending on factors such as the type of trial or number of patients enrolled. To test the effectiveness of our system, we first implement a simple and robust permutation based synthetic data generator. We then use the synthetic data generator coupled with our querying language to identify significant relationships among variables in a realistic clinical trial dataset.
Indexed as
Identifiers
31797635PMC6954005What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.